1
2
3
4
5
6
7
8
9
10
11
12
13
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
House Bill 3192
Sponsored by Representatives OWENS, MCLAIN; Representatives GOMBERG, MARSH, MCINTIRE, NELSON,
OSBORNE, SCHARF, SOSA, VALDERRAMA, WRIGHT, Senators CAMPOS, FREDERICK, GELSER BLOUIN,
GOLDEN, MEEK, NASH, PATTERSON, STARR (Presession filed.)
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced.The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act gives money to the OHA to test newborns for five specific diseases. (Flesch
Readability Score: 65.7).
Appropriates moneys from the General Fund to the Oregon Health Authority for the purpose
of screening newborns for five specific diseases under the Northwest Regional Newborn Bloodspot
ScreeningProgram.
A BILL FOR AN ACT
Relating to newborn bloodspot screening.
Be It Enacted by the People of the State of Oregon:
SECTION 1. In addition to and not in lieu of any other appropriation, there is appropri-
ated to the Oregon Health Authority, for the biennium beginning July 1, 2025, out of the
General Fund, the amount of $4,000,000, for the purpose of screening newborns under the
Northwest Regional Newborn Bloodspot Screening Program for:
(1) Mucopolysaccharidosis type II (MPS II).
(2) Guanidinoacetate methyltransferase deficiency (GAMT).
(3) Krabbe disease.
(4) Duchenne muscular dystrophy.
(5) Cytomegalovirus.
NOTE:Matter in boldfaced type in an amended section is new; matter [italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 1910